[1] 周春燕,段东.外周血炎性标志物在甲状腺癌中的应用进展[J].现代肿瘤医学,2021,29(06):1062-1066.
ZHOU CY,DUAN D.Application of peripheral blood inflammatory markers in thyroid cancer[J].Modern Oncology,2021,29(06):1062-1066.
[2] HU J,YUAN IJ,MIRSHAHIDI S,et al.Thyroid carcinoma:phenotypic features,underlying biology and potential relevance for targeting therapy[J].Int J Mol Sci,2021,22(4):1950.
[3] YAN T,QIU W,SONG J,et al.ARHGAP36 regulates proliferation and migration in papillary thyroid carcinoma cells[J].J Mol Endocrinol,2021,66(1):1-10.
[4] LIU C,XIAO C,CHEN J,et al.Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma:a study of 966 patients[J].BMC Cancer,2019,19(1):622.
[5] FAN L,TIAN Q,XIU C,et al.High iodine nutrition may be a risk factor for cervical lymph node metastasis in papillary thyroid cancer patients[J].Ann Nutr Metab,2021,77(2):90-99.
[6] ZHANG L,YU D.Exosomes in cancer development,metastasis,and immunity[J].Biochim Biophys Acta Rev Cancer,2019,1871(2):455-468.
[7] SUN Z,SHI K,YANG S,et al.Effect of exosomal miRNA on cancer biology and clinical applications[J].Mol Cancer,2018,17(1):147.
[8] DAI D,TAN Y,GUO L,et al.Identification of exosomal miRNA biomarkers for diagnosis of papillary thyroid cancer by small RNA sequencing[J].Eur J Endocrinol,2020,182(1):111-121.
[9] HAN JH,WU L,YU SL,et al.Values of iodine metabolism biomarkers in assessing the iodine nutrition status in surgically treated patients with thyroid disease[J].Acta Academiae Medicinae Sinicae,2015,37(2):221-225.
[10] ZHENG R,ZHANG S,ZENG H,et al.Cancer incidence and mortality in China,2016[J].Journal of the National Cancer Center,2022,2(1):1-9.
[11] YU J,DENG Y,LIU T,et al.Lymph node metastasis prediction of papillary thyroid carcinoma based on transfer learning radiomics[J].Nat Commun,2020,11(1):4807.
[12] 朱星成,李博,孙继芹,等.血清外泌体微小RNA在肺癌中的临床应用进展[J].实用检验医师杂志,2022,14(02):212-215.
ZHU XC,LI B,SUN JQ,et al.Research progress on clinical application for microRNA of serum exosomes in lung cancer[J].Chinese Journal of Clinical Pathologist,2022,14(02):212-215.
[13] JIANG K,LI G,CHEN W,et al.Plasma exosomal miR-146b-5p and miR-222-3p are potential biomarkers for lymph node metastasis in papillary thyroid carcinomas[J].Onco Targets Ther,2020,13:1311-1319.
[14] CHEN W,LI G,LI Z,et al.Evaluation of plasma exosomal miRNAs as potential diagnostic biomarkers of lymph node metastasis in papillary thyroid carcinoma[J].Endocrine,2022,75(3):846-855.
[15] WANG F,WANG Y,WANG L,et al.Strong association of high urinary iodine with thyroid nodule and papillary thyroid cancer[J].Tumour Biol,2014,35(11):11375-11379.
[16] ZHANG D,XU X,LI J,et al.High iodine effects on the proliferation,apoptosis,and migration of papillary thyroid carcinoma cells as a result of autophagy induced by BRAF kinase[J].Biomed Pharmacother,2019,120:109476.
[17] BAM M,YANG X,BUSBEE BP,et al.Increased H3K4me3 methylation and decreased miR-7113-5p expression lead to enhanced Wnt/β-catenin signaling in immune cells from PTSD patients leading to inflammatory phenotype[J].Mol Med,2020,26(1):110.
[18] 邹丹,赵爱琴,王晓庆,等.双特异性磷酸酶14、微小RNA-873-3p在宫颈癌组织中的表达及与临床病理特征和预后的关系[J].中国性科学,2022,31(10):113-117.
ZOU D,ZHAO AQ,WANG XQ,et al.Expression of DUSP14 and miR-873-3p in cervical cancer tissues and their relationship with clinicopathological characteristics and prognosis[J].Chinese Journal of Human Sexuality,2022,31(10):113-117.
[19] ZHUO X,ZHOU W,LI D,et al.Plasma microRNA expression signature involving miR-548q,miR-630 and miR-940 as biomarkers for nasopharyngeal carcinoma detection[J].Cancer Biomark,2018,23(4):579-587.
[20] WU ZH,LIN C,LIU CC,et al.MiR-616-3p promotes angiogenesis and EMT in gastric cancer via the PTEN/AKT/mTOR pathway[J].Biochem Biophys Res Commun,2018,501(4):1068-1073.
[21] CHEN C,MA J,MIAO CS,et al.Trigonelline induces autophagy to protect mesangial cells in response to high glucose via activating the miR-5189-5p-AMPK pathway[J].Phytomedicine,2021,92:153614.
[22] ZHANG L,SHI B,HU M,et al.HIF-1α and Caspase-3 expression in aggressive papillary thyroid carcinoma[J].World J Surg Oncol,2022,20(1):353.
[23] LI R,ZHANG Y,XIANG R,et al.Analysis of the mechanism of maslinic acid on papillary thyroid carcinoma based on RNA-Seq technology[J].Evid Based Complement Alternat Med,2022,2022:7000531.
[24] ZHANG H,GAO B,SHI B.Identification of differentially expressed kinase and screening potential anticancer drugs in papillary thyroid carcinoma[J].Dis Markers,2016,2016:2832980.